ClariVest Asset Management LLC increased its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 23.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 75,473 shares of the biopharmaceutical company’s stock after acquiring an additional 14,140 shares during the quarter. ClariVest Asset […]